BBVA USA Bancshares’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
$1.03M Sell
17,961
-263
-1% -$14.2K 0.05% 302
2020
Q4
$916K Sell
18,224
-4,495
-20% -$179K 0.05% 299
2020
Q3
$670K Sell
22,719
-628
-3% -$18.2K 0.04% 319
2020
Q2
$587K Buy
23,347
+2,257
+11% +$56.3K 0.04% 334
2020
Q1
$387K Buy
21,090
+4,117
+24% +$118K 0.03% 366
2019
Q4
$563K Buy
16,973
+3,108
+22% +$97.4K 0.03% 352
2019
Q3
$431K Buy
13,865
+1,315
+10% +$40K 0.03% 307
2019
Q2
$438K Buy
12,550
+5,262
+72% +$170K 0.03% 388
2019
Q1
$214K Buy
+7,288
New +$206K 0.01% 492
2018
Q4
Sell
-8,222
Closed -$289K 512
2018
Q3
$289K Buy
8,222
+1,884
+30% +$75.1K 0.02% 468
2018
Q2
$259K Buy
+6,338
New +$256K 0.02% 477

Other funds holding ACHC

BBVA USA Bancshares's ACHC Position: Q1 2021 in Review

BBVA USA Bancshares reduced its Acadia Healthcare (ACHC) stake by 1.4% in Q1 2021, selling an estimated $14.2K and leaving 17,961 shares worth $1.03M. The position accounts for 0.05% of the portfolio, ranked #302.

BBVA USA Bancshares first reported a position in ACHC in Q2 2018 and has held it in 11 quarters since. 271 funds tracked by Wall St. Rank hold ACHC as of Q1 2021.

  • BBVA USA Bancshares held 17,961 shares of Acadia Healthcare worth $1.03M as of Q1 2021.
  • BBVA USA Bancshares sold 263 Acadia Healthcare shares in Q1 2021, an estimated $14.2K.
  • Acadia Healthcare made up 0.05% of BBVA USA Bancshares's portfolio in Q1 2021, its #302 holding.
  • BBVA USA Bancshares first reported a position in Acadia Healthcare in Q2 2018 and has held it in 11 quarters since.
  • 271 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2021.

Based on BBVA USA Bancshares's 13F filing for Q1 2021, filed 23 Apr 2021.